106 studies found for:    "Huntington disease"
Show Display Options
Rank Status Study
21 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
22 Completed Apathy Cure Through Bupropion in Huntington's Disease
Conditions: Apathy;   Huntington's Disease
Interventions: Drug: Bupropion;   Drug: Placebo
23 Completed A Study of ACR16 for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
24 Recruiting Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
Condition: Huntington Disease
Intervention:
25 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
26 Completed A Study of Treatment With ACR16 in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: ACR16;   Drug: Placebo
27 Completed Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Condition: Huntington's Disease
Intervention:
28 Active, not recruiting Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
Condition: Huntington Disease
Interventions: Drug: (2)-epigallocatechin-3-gallate (EGCG);   Drug: Placebo
29 Completed The Effect of Video Game Exercise on Dynamic Balance and Gait in Individuals With Huntington's Disease
Condition: Huntington's Disease
Interventions: Other: Video game exercise using Dance Dance Revolution;   Other: hand-held video game
30 Completed Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
Condition: Huntington's Disease
Intervention: Drug: sodium phenylbutyrate
31 Completed
Has Results
Creatine Safety & Tolerability in Huntington's Disease
Condition: Huntington's Disease (HD)
Intervention: Drug: Creatine monohydrate
32 Completed A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
33 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington's Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
34 Terminated Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea
Conditions: Huntington's Disease;   Chorea
Interventions: Drug: AFQ056;   Drug: Placebo
35 Completed A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Other: Placebo;   Drug: Dimebon
36 Recruiting A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: Pridopidine;   Other: Placebo
37 Recruiting Exercise Effects in Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Exercise training
38 Completed 31P-MRS and Huntington Disease
Condition: Huntington Disease
Interventions: Other: 31P-MR spectroscopy;   Other: 31P-RMN spectroscopy
39 Completed Minocycline in Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Minocycline
40 Completed Riluzole in Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Riluzole

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years